ANDROGEN RECEPTOR VARIATION AFFECTS PROSTATE CANCER PROGRESSION AND DRUG RESISTANCE

Significant therapeutic progress has been made in treating prostate cancer in recent years. Drugs such as enzalutamide, abiraterone, and cabazitaxel have expanded the treatment armamentarium, although it is not completely clear which of these drugs are the most-effective option for individual patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacol Res
Hlavní autoři: McCrea, Edel, Sissung, Tristan M., Price, Douglas K., Chau, Cindy H., Figg, William D.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154811/
https://ncbi.nlm.nih.gov/pubmed/27725309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.10.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky